Regeneron Pharmaceuticals Inc (REGN)
843.60
+5.40
(+0.64%)
USD |
NASDAQ |
Nov 01, 16:00
843.60
0.00 (0.00%)
After-Hours: 20:00
Regeneron Pharmaceuticals Market Cap: 92.70B for Nov. 1, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 01, 2024 | 92.70B |
| October 31, 2024 | 92.11B |
| October 30, 2024 | 101.40B |
| October 29, 2024 | 101.90B |
| October 28, 2024 | 102.04B |
| October 25, 2024 | 102.53B |
| October 24, 2024 | 102.08B |
| October 23, 2024 | 103.45B |
| October 22, 2024 | 105.97B |
| October 21, 2024 | 106.65B |
| October 18, 2024 | 109.09B |
| October 17, 2024 | 109.92B |
| October 16, 2024 | 110.99B |
| October 15, 2024 | 111.94B |
| October 14, 2024 | 111.69B |
| October 11, 2024 | 111.84B |
| October 10, 2024 | 110.01B |
| October 09, 2024 | 111.46B |
| October 08, 2024 | 110.70B |
| October 07, 2024 | 109.68B |
| October 04, 2024 | 111.53B |
| October 03, 2024 | 111.72B |
| October 02, 2024 | 114.55B |
| October 01, 2024 | 115.28B |
| September 30, 2024 | 115.76B |
| Date | Value |
|---|---|
| September 27, 2024 | 114.94B |
| September 26, 2024 | 114.64B |
| September 25, 2024 | 113.67B |
| September 24, 2024 | 115.30B |
| September 23, 2024 | 120.37B |
| September 20, 2024 | 126.22B |
| September 19, 2024 | 126.79B |
| September 18, 2024 | 125.54B |
| September 17, 2024 | 126.41B |
| September 16, 2024 | 127.11B |
| September 13, 2024 | 127.14B |
| September 12, 2024 | 128.36B |
| September 11, 2024 | 125.83B |
| September 10, 2024 | 125.26B |
| September 09, 2024 | 126.19B |
| September 06, 2024 | 124.73B |
| September 05, 2024 | 126.83B |
| September 04, 2024 | 130.01B |
| September 03, 2024 | 128.84B |
| August 30, 2024 | 130.59B |
| August 29, 2024 | 129.96B |
| August 28, 2024 | 132.20B |
| August 27, 2024 | 132.48B |
| August 26, 2024 | 132.21B |
| August 23, 2024 | 132.18B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
34.15B
Minimum
Nov 04 2019
132.48B
Maximum
Aug 27 2024
74.89B
Average
69.64B
Median
Market Cap Benchmarks
| Amgen Inc | 171.59B |
| Eli Lilly and Co | 777.42B |
| Pfizer Inc | 159.18B |
| Biogen Inc | 25.32B |
| Vertex Pharmaceuticals Inc | 121.60B |
Market Cap Related Metrics
| PE Ratio | 20.88 |
| PS Ratio | 7.012 |
| PEG Ratio | 1.368 |
| Price to Book Value | 3.161 |
| Price to Free Cash Flow | 29.25 |
| Price | 843.60 |
| Earnings Yield | 4.79% |
| PEGY Ratio | 1.368 |
| Operating PE Ratio | 23.74 |
| Normalized PE Ratio | 22.04 |